MedTrace Logo

Effect of a Lacidofil® STRONG in Healthy Adults Taking Antibiotic Treatment

NCT01941160 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2014-05-14

No results posted yet for this study

Summary

The objectives of this study are to evaluate stool consistency and stool frequency during and up to 8 weeks following a 7 day antibiotic treatment with Amoxicillin/Clavulanic Acid 875mg BID.

Conditions

  • Antibiotic Associated Diarrhea

Interventions

DIETARY_SUPPLEMENT

Lacidofil® STRONG

Lacidofil® STRONG capsule twice daily

DIETARY_SUPPLEMENT

Placebo

Placebo capsule twice daily

Sponsors & Collaborators

  • Lallemand Health Solutions

    collaborator INDUSTRY

  • KGK Science Inc.

    lead INDUSTRY

Principal Investigators

  • Dale Wilson, MD · KGK Science Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01941160 on ClinicalTrials.gov